India has emerged as a global hub for pharmaceutical innovation and manufacturing, especially in combating public health challenges like tuberculosis (TB). A critical development in TB treatment is Bedaquiline, a medication specifically designed to treat multidrug-resistant tuberculosis (MDR-TB). With the rise in MDR-TB cases worldwide, India plays